Critical Management Strategies for Cardiovascular Involvementin Light Chain Amyloidosis
Light chain amyloidosis (AL) is a kind of rare disease. The misfolding of the light chain of monoclonal immunoglobulin forms amyloid substances and deposit in different tissues and organs, resulting in organ dysfunction. The heart involvement is represented as light chain cardiac amyloidosis (AL-CA)...
Main Authors: | SHI Yunjing, JIN Wei |
---|---|
Format: | Article |
Language: | zho |
Published: |
Editorial Office of Journal of Rare Diseases
2023-01-01
|
Series: | 罕见病研究 |
Subjects: | |
Online Access: | https://jrd.chard.org.cn/article/doi/10.12376/j.issn.2097-0501.2023.01.004 |
Similar Items
-
What is new in amyloidosis treatment? Part 1: Light chains
by: Gisela Bendelman, et al.
Published: (2023-12-01) -
How I manage systemic light chain amyloidosis
by: Gregory P. Kaufman, et al.
Published: (2021-09-01) -
What is New in Diagnosis of Amyloidosis?
by: María A. Marco, et al.
Published: (2023-12-01) -
Physiology, Diagnosis and Treatment of Cardiac Light Chain Amyloidosis
by: Agnieszka Stelmach-Gołdyś, et al.
Published: (2022-02-01) -
Extensive Amyloid Purpura: An Unusual Presentation of Myeloma-associated Light Chain Amyloidosis
by: Nor Fazil Jaber, et al.
Published: (2023-06-01)